Mir-217 promotes inflammation and fibrosis in high glucose cultured rat glomerular mesangial cells via Sirt1/HIF-1α signaling pathway

Diabetes/Metabolism Research and Reviews

Volumn 32, Issue 6, 2016, Pages 534-543

  Shao, Ying ^a   Lv, Chuan ^a   Wu, Can ^a   Zhou, Yuehong ^b   Wang, Qiuyue ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Division of Endocrinology Shenyang No 8 Hospital   (China)

Author keywords

diabetic nephropathy; hypoxia inducible factor 1 ; microRNA; microRNA 217; silent information regulator 1

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; ENDOTHELIN 1; FIBRONECTIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LIPOFECTAMINE; MICRORNA; MICRORNA 217; RESVERATROL; SILENT INFORMATION REGULATOR 1; SILENT INFORMATION REGULATOR PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROSIS; GENE SILENCING; GENETIC TRANSFECTION; GLOMERULAR MESANGIAL CELL; GLUCOSE INTAKE; IN VITRO STUDY; INFLAMMATION; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

EID: 84986000541     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2788     Document Type: Article

References (27)

1. Yiu WH, Lin M, Tang SC. Toll-like receptor activation: from renal inflammation to fibrosis. Kidney Int Suppl 2014; 4(1): 20–25 [PubMed: 26312146].
2. Wu MH, Huang CY, Lin JA, et al. Endothelin-1 promotes vascular endothelial growth factor-dependent angiogenesis in human chondrosarcoma cells. Oncogene 2014; 33(13): 1725–1735 [PubMed: 23584483].
3. Jing J, Dou TT, Yang JQ, et al. Role of endothelin-1 in the skin fibrosis of systemic sclerosis. Eur Cytokine Netw 2015; 26(1): 10–14 [PubMed: 25990837].
4. Saleh MA, Pollock DM. Endothelin in renal inflammation and hypertension. Contrib Nephrol 2011; 172: 160–170 [PubMed: 21893997].
5. Saldanha JF, Leal Vde O, Stenvinkel P, et al. Resveratrol: why is it a promising therapy for chronic kidney disease patients? Oxid Med Cell Longev 2013; 2013: 963217 [PubMed: 24489988].
6. Kume S, Kitada M, Kanasaki K, et al. Anti-aging molecule, Sirt1: a novel therapeutic target for diabetic nephropathy. Arch Pharm Res 2013; 36(2): 230–236 [PubMed: 23361587].
7. Zbytek B, Peacock DL, Seagroves TN, et al. Putative role of HIF transcriptional activity in melanocytes and melanoma biology. Dermatoendocrinol 2013; 5(2): 239–251 [PubMed: 24194964].
8. Takiyama Y, Harumi T, Watanabe J, et al. Tubular injury in a rat model of type 2 diabetes is prevented by metformin: a possible role of HIF-1alpha expression and oxygen metabolism. Diabetes 2011; 60(3): 981–992 [PubMed: 21282369].
9. Ortega A, Fernandez A, Arenas MI, et al. Outcome of acute renal injury in diabetic mice with experimental endotoxemia: role of hypoxia-inducible factor-1 alpha. J Diabetes Res 2013; 2013: 254529 [PubMed: 23984430].
10. Laemmle A, Lechleiter A, Roh V, et al. Inhibition of SIRT1 impairs the accumulation and transcriptional activity of HIF-1alpha protein under hypoxic conditions. PLoS One 2012; 7(3): e33433 [PubMed: 22479397].
11. Fiorentino L, Cavalera M, Mavilio M, et al. Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs. Acta Diabetol 2013; 50(6): 965–969 [PubMed: 23797704].
12. Shi S, Yu L, Zhang T, et al. Smad2-dependent downregulation of miR-30 is required for TGF-beta-induced apoptosis in podocytes. PLoS One 2013; 8(9): e75572 [PubMed: 24086574].
13. Zhang S, Liu L, Wang R, et al. MicroRNA-217 promotes angiogenesis of human cytomegalovirus-infected endothelial cells through downregulation of SIRT1 and FOXO3A. PLoS One 2013; 8(12): e83620 [PubMed: 24376725].
14. Bae JU, Lee SJ, Seo KW, et al. SIRT1 attenuates neointima formation by inhibiting HIF-1alpha expression in neointimal lesion of a murine wire-injured femoral artery. Int J Cardiol 2013; 168(4): 4393–4396 [PubMed: 23706319].
15. Yoon H, Shin SH, Shin DH, et al. Differential roles of Sirt1 in HIF-1alpha and HIF-2alpha mediated hypoxic responses. Biochem Biophys Res Commun 2014; 444(1): 36–43 [PubMed: 24423936].
16. Menghini R, Casagrande V, Cardellini M, et al. MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 2009; 120(15): 1524–1532 [PubMed: 19786632].
17. Kitada M, Koya D. SIRT1 in type 2 diabetes: mechanisms and therapeutic potential. Diabetes Metab J 2013; 37(5): 315–325 [PubMed: 24199159].
18. Hasegawa K, Wakino S, Simic P, et al. Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes. Nat Med 2013; 19(11): 1496–1504 [PubMed: 24141423].
19. Kim KE, Kim H, Heo RW, et al. Myeloid-specific SIRT1 deletion aggravates hepatic inflammation and steatosis in high-fat diet-fed mice. Korean J Physiol Pharmacol 2015; 19(5): 451–460 [PubMed: 26330758].
20. Mortuza R, Feng B, Chakrabarti S. SIRT1 reduction causes renal and retinal injury in diabetes through endothelin 1 and transforming growth factor beta1. J Cell Mol Med 2015; 19(8): 1857–1867 [PubMed: 25753689].
21. Matoba K, Kawanami D, Okada R, et al. Rho-kinase inhibition prevents the progression of diabetic nephropathy by downregulating hypoxia-inducible factor 1alpha. Kidney Int 2013; 84(3): 545–554 [PubMed: 23615507].
22. Lim JH, Lee YM, Chun YS, et al. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol Cell 2010; 38(6): 864–878 [PubMed: 20620956].
23. Isoe T, Makino Y, Mizumoto K, et al. High glucose activates HIF-1-mediated signal transduction in glomerular mesangial cells through a carbohydrate response element binding protein. Kidney Int 2010; 78(1): 48–59 [PubMed: 20375990].
24. Westra J, Molema G, Kallenberg CG. Hypoxia-inducible factor-1 as regulator of angiogenesis in rheumatoid arthritis—therapeutic implications. Curr Med Chem 2010; 17(3): 254–263 [PubMed: 20214567].
25. Lokmic Z, Musyoka J, Hewitson TD, et al. Hypoxia and hypoxia signaling in tissue repair and fibrosis. Int Rev Cell Mol Biol 2012; 296: 139–185 [PubMed: 22559939].
26. Deng S, Zhu S, Wang B, et al. Chronic pancreatitis and pancreatic cancer demonstrate active epithelial–mesenchymal transition profile, regulated by miR-217-SIRT1 pathway. Cancer Lett 2014; 355(2): 184–191 [PubMed: 25172416].
27. Yin H, Hu M, Zhang R, et al. MicroRNA-217 promotes ethanol-induced fat accumulation in hepatocytes by down-regulating SIRT1. J Biol Chem 2012; 287(13): 9817–9826 [PubMed: 22308024].